Purchases and Sales Made in Q3 2021 in Lexaria Bioscience Corp. (LEXX)
This table provides information about the institutional ownership of Lexaria Bioscience Corp. (LEXX) during Q3 2021. The information is specifically focused on institutions that hold shares of Lexaria Bioscience Corp..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 15, 2021
Q3 2021
|
Invenomic Capital Management LP
Boston, MA |
BUY
|
- |
35.3K+ 11.13% |
$190K - $298K
|
352K
$814K
|
|
Nov 12, 2021
Q3 2021
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
11.9KNew |
$64.4K - $101K
|
11.9K
$27.6K
|
|
Nov 12, 2021
Q3 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
4.86K+ 18.7% |
$26.2K - $41K
|
30.8K
$71.2K
|
|
Nov 15, 2021
Q3 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
1KNew |
$5.39K - $8.44K
|
1K
$2.31K
|
|
Nov 05, 2021
Q3 2021
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
200+ 118.34% |
$1.08K - $1.69K
|
369
$852
|
|
Nov 15, 2021
Q3 2021
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
140+ 55.12% |
$755 - $1.18K
|
394
$910
|
|
Nov 12, 2021
Q3 2021
|
Gables Capital Management Inc.
|
BUY
|
- |
13New |
$70.1 - $110
|
13
$30
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 15, 2021
Q3 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-4- 13.79% |
$21.6 - $33.8
|
25
$57.8
|
|
Nov 15, 2021
Q3 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-251Closed |
$1.35K - $2.12K
|
0
$0
|
|
Nov 12, 2021
Q3 2021
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-1.38K- 2.74% |
$7.45K - $11.7K
|
49K
$113K
|
|
Nov 12, 2021
Q3 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-17.2KClosed |
$92.7K - $145K
|
0
$0
|